Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $7,423 | 6 | 96.6% |
| Food and Beverage | $171.88 | 3 | 2.2% |
| Education | $86.07 | 5 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $7,471 | 8 | $0 (2023) |
| Astellas Pharma US Inc | $123.55 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $47.25 | 2 | $0 (2022) |
| PFIZER INC. | $21.80 | 2 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $17.02 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.02 | 1 | Regeneron Healthcare Solutions, Inc. ($17.02) |
| 2023 | $7,471 | 8 | Merck Sharp & Dohme LLC ($7,471) |
| 2022 | $36.18 | 1 | E.R. Squibb & Sons, L.L.C. ($36.18) |
| 2021 | $11.07 | 1 | E.R. Squibb & Sons, L.L.C. ($11.07) |
| 2019 | $21.80 | 2 | PFIZER INC. ($21.80) |
| 2017 | $123.55 | 1 | Astellas Pharma US Inc ($123.55) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LENVIMA | Travel and Lodging | In-kind items and services | $6,375.35 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LENVIMA | Travel and Lodging | In-kind items and services | $282.00 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $37.76 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LENVIMA | Travel and Lodging | In-kind items and services | $282.00 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LENVIMA | Travel and Lodging | In-kind items and services | $108.17 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LENVIMA | Travel and Lodging | In-kind items and services | $93.08 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LENVIMA | Travel and Lodging | In-kind items and services | $282.00 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2022 | E.R. Squibb & Sons, L.L.C. | SPRYCEL (Drug) | Education | In-kind items and services | $36.18 | General |
| Category: Oncology | ||||||
| 10/26/2021 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Education | In-kind items and services | $11.07 | General |
| Category: Hematology | ||||||
| 04/11/2019 | PFIZER INC. | BESPONSA (Biological) | Education | In-kind items and services | $10.90 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2019 | PFIZER INC. | BESPONSA (Biological) | Education | In-kind items and services | $10.90 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $123.55 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 256 | 458 | $229,857 | $47,703 |
| 2022 | 7 | 218 | 420 | $163,293 | $36,239 |
| 2021 | 7 | 374 | 653 | $284,443 | $66,681 |
| 2020 | 8 | 277 | 525 | $215,695 | $46,081 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 48 | 124 | $63,767 | $14,472 | 22.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 107 | $54,885 | $11,225 | 20.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 61 | $40,687 | $8,621 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 41 | 71 | $27,123 | $5,460 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 77 | $31,083 | $5,275 | 17.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 18 | 18 | $12,312 | $2,651 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 138 | $49,542 | $10,216 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 42 | 123 | $44,157 | $9,403 | 21.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 26 | 42 | $20,191 | $4,955 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 41 | $19,762 | $4,906 | 24.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $6,750 | $1,681 | 24.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 19 | $6,498 | $1,611 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $7,524 | $1,421 | 18.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 15 | 15 | $4,965 | $1,245 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 13 | 16 | $3,904 | $800.62 | 20.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 90 | 198 | $93,422 | $22,192 | 23.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 50 | 139 | $65,302 | $15,681 | 24.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 60 | 95 | $33,804 | $7,569 | 22.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 65 | $23,206 | $5,074 | 21.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 31 | 31 | $13,668 | $3,427 | 25.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 33 | $11,150 | $2,841 | 25.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 17 | 17 | $11,339 | $2,783 | 24.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 19 | 19 | $12,862 | $2,757 | 21.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 35 | 42 | $10,248 | $2,337 | 22.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 14 | 14 | $9,442 | $2,020 | 21.4% |
About Sowmya Korapati
Sowmya Korapati is a Hematology & Oncology healthcare provider based in Worcester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1003108259.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sowmya Korapati has received a total of $7,681 in payments from pharmaceutical and medical device companies, with $17.02 received in 2024. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($7,423).
As a Medicare-enrolled provider, Korapati has provided services to 1,125 Medicare beneficiaries, totaling 2,056 services with total Medicare billing of $196,704. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Worcester, MA
- Active Since 05/06/2011
- Last Updated 10/27/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1003108259
Products in Payments
- KEYTRUDA (Biological) $7,471
- Xtandi (Drug) $123.55
- SPRYCEL (Drug) $36.18
- BESPONSA (Biological) $21.80
- LIBTAYO (Biological) $17.02
- Pomalyst (Drug) $11.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Worcester
Dr. Tariq Mughal, M.d, M.D
Hematology & Oncology — Payments: $342,612
Viola Zhu, Md Phd, MD PHD
Hematology & Oncology — Payments: $270,026
James Rooney, M.d, M.D
Hematology & Oncology — Payments: $20,015
Dr. Shyam Patel, M.d., Ph.d, M.D., PH.D
Hematology & Oncology — Payments: $14,978
Madhavi Toke, Md, MD
Hematology & Oncology — Payments: $9,823
Vijay Kasturi, M.d, M.D
Hematology & Oncology — Payments: $9,810